Bone marrow necrosis secondary to imatinib usage, mimicking spinal metastasis on magnetic resonance imaging and FDG-PET/CT: Case report

Journal of Neurosurgery: Spine

Volumn 16, Issue 1, 2012, Pages 57-60

  Aras, Yavuz ^a   Akcakaya, Mehmet Osman ^a   Unal, Seher N ^a   Bilgic, Bilge ^a   Unal, Omer Faruk ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Bone marrow necrosis; FDG PET CT; Gastrointestinal stromal tumor; Imatinib; Oncology

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IMATINIB; OPIATE;

AGED; ARTICLE; BACKACHE; BONE MARROW NECROSIS; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PATIENT CARE; SPINAL CORD METASTASIS; SURGICAL TECHNIQUE; THORACOLUMBAR SPINE;

AGED; ANTINEOPLASTIC AGENTS; BONE MARROW; BONE MARROW DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MAGNETIC RESONANCE IMAGING; NECROSIS; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PYRIMIDINES; SPINAL NEOPLASMS;

EID: 84855388875     PISSN: 15475654     EISSN: 15475646     Source Type: Journal    
DOI: 10.3171/2011.9.SPINE11401     Document Type: Article

References (25)

1. Berman E, Nicolaides M, Maki RG, Fleisher M, Chanel S, Scheu K, et al: Altered bone and mineral metabolism in patients receiving imatinib mesylate. N Engl J Med 354:2006-2013, 2006
2. Böhm P, Huber J: The surgical treatment of bony metastases of the spine and limbs. J Bone Joint Surg Br 84:521-529, 2002 (Pubitemid 34578501)
3. Burton C, Azzi A, Kerridge I: Adverse events after imatinib mesylate therapy. N Engl J Med 346:712-713, 2002 (Pubitemid 34815885)
4. Campiotti L, Codari R, Appio L, Ultori C, Solbiati F, Maria Grandi A, et al: Bone marrow necrosis related to imatinib mesylate therapy for cml bilineal blast crisis. Leuk Res 31:1768-1770, 2007 (Pubitemid 350051395)
5. de Mestier P, des Guetz G: Treatment of gastrointestinal stromal tumors with imatinib mesylate: a major breakthrough in the understanding of tumor-specific molecular characteristics. World J Surg 29:357-362, 2005
6. Druker BJ: Imatinib as a paradigm of targeted therapies. Adv Cancer Res 91:1-30, 2004
7. Druker BJ: Translation of the Philadelphia chromosome into therapy for CML. Blood 112:4808-4817, 2008
8. Gokaslan ZL, York JE, Walsh GL, McCutcheon IE, Lang FF, Putnam JB Jr, et al: Transthoracic vertebrectomy for metastatic spinal tumors. J Neurosurg 89:599-609, 1998 (Pubitemid 28440929)
9. Grigolon MV, Delbeke D: F-18 FDG uptake in a bone infarct: a case report. Clin Nucl Med 26:613-614, 2001
10. Kanberoglu K, Mihmanli I, Kurugoglu S, Ogut G, Kantarci F: Bone marrow changes adjacent to the sacroiliac joints after pelvic radiotherapy mimicking metastases on MRI. Eur Radiol 11:1748-1752, 2001 (Pubitemid 32821382)
11. Kostuik JP: Differential diagnosis and surgical treatment of metastatic spine tumors, in Frymoyer JW (ed): The Adult Spine, ed 2. Philadelphia: Lippincott-Raven, 1997, Vol 1, pp 989-1014
12. Lieberman I, Reinhardt MK: Vertebroplasty and kyphoplasty for osteolytic vertebral collapse. Clin Orthop Relat Res 415 (415 Suppl):S176-S186, 2003 (Pubitemid 37323335)
13. Love C, Tomas MB, Tronco GG, Palestro CJ: FDG PET of infection and inflammation. Radiographics 25:1357-1368, 2005 (Pubitemid 41695350)
14. Matsue K, Takeuchi M, Koseki M, Uryu H: Bone marrow necrosis associated with the use of imatinib mesylate in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia. Ann Hematol 85:542-544, 2006 (Pubitemid 44283098)
15. Miettinen M, Lasota J: Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 438:1-12, 2001 (Pubitemid 32128184)
16. Miettinen M, Majidi M, Lasota J: Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer 38 (Suppl 5):S39-S51, 2002
17. Paydas S, Ergin M, Baslamisli F, Yavuz S, Zorludemir S, Sahin B, et al: Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature. Am J Hematol 70:300-305, 2002 (Pubitemid 34810507)
18. Ray-Coquard I, Cesne AL, Blay JY: [STI571 and gastro intestinal stromal tumors.] Bull Cancer 88:661-662, 2001 (Fr)
19. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M: CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 11:728-734, 1998 (Pubitemid 28381606)
20. Savage DG, Antman KH: Imatinib mesylate - a new oral targeted therapy. N Engl J Med 346:683-693, 2002 (Pubitemid 34815874)
21. Sohn MH, Jeong HJ, Lim ST, Song SH, Yim CY: F-18 FDG uptake in osteonecrosis mimicking bone metastasis on PET/CT images. Clin Nucl Med 32:496-497, 2007 (Pubitemid 46791482)
22. Swift PS: Radiation for spinal metastatic tumors. Orthop Clin North Am 40:133-144, vii, 2009
23. Tamura T, Tasaka T, Fujimoto M, Matsuhashi Y, Fukumot T, Mano S, et al: Massive bone marrow necrosis in a patient with chronic myelocytic leukemia following imatinib mesylate therapy. Haematologica 89:ECR32, 2004
24. Vanel D, Bonvalot S, Pechoux CL, Cioffi A, Domont J, Cesne AL: Imatimid-induced bone marrow necrosis detected on MRI examination and mimicking bone metastases. Skeletal Radiol 36:895-898, 2007 (Pubitemid 47278643)
25. Wowra B, Muacevic A, Zausinger S, Tonn JC: Radiosurgery for spinal malignant tumors. Dtsch Arztebl Int 106:106-112, 2009